MANGOCEUTICALS, INC. (MGRX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US56270V2051
MANGOCEUTICALS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 456,021.00 USD |
| Gross profit | 250,386.00 USD |
| Operating income | -18.03 m USD |
| EBIT | -20.54 m USD |
| Net income | -20.64 m USD |
| Diluted EPS – continuing operations | -2.17 USD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About MANGOCEUTICALS, INC.
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
More stocks
- Polomar Health Services, Inc. (PMHS)
- VisitIQ Corp. (VIIQ)
- Borqs Technologies, Inc. (BRQSF)
- CXApp Inc. (CXAI)
- Xenetic Biosciences, Inc. (XBIO)
- Silo Pharma, Inc. (SILO)
- zSpace, Inc. (ZSPC)
- Dragonfly Energy Holdings Corp. (DFLI)
- SelectQuote, Inc. (SLQT)
- SOCKET MOBILE, INC. (SCKT)
- Golden Minerals Co (AUMN)
- BASANITE, INC. (BASA)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.